000144854 001__ 144854
000144854 005__ 20240229112640.0
000144854 0247_ $$2doi$$a10.1007/s00432-019-03029-4
000144854 0247_ $$2pmid$$apmid:31541339
000144854 0247_ $$2ISSN$$a0084-5353
000144854 0247_ $$2ISSN$$a0171-5216
000144854 0247_ $$2ISSN$$a0943-9382
000144854 0247_ $$2ISSN$$a1432-1335
000144854 0247_ $$2altmetric$$aaltmetric:66962675
000144854 037__ $$aDKFZ-2019-02278
000144854 041__ $$aeng
000144854 082__ $$a610
000144854 1001_ $$00000-0002-0250-9017$$aBösch, Florian$$b0
000144854 245__ $$aMolecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
000144854 260__ $$aBerlin$$bSpringer42162$$c2019
000144854 264_1 $$2Crossref$$3online$$bSpringer Science and Business Media LLC$$c2019-09-20
000144854 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2019-11-01
000144854 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2019-11-01
000144854 3367_ $$2DRIVER$$aarticle
000144854 3367_ $$2DataCite$$aOutput Types/Journal article
000144854 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1577095058_24059
000144854 3367_ $$2BibTeX$$aARTICLE
000144854 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144854 3367_ $$00$$2EndNote$$aJournal Article
000144854 520__ $$aGastric cancer is the third leading cause of cancer-related death. Recently, innovative diagnostic and prognostic molecular subtypes have been proposed. We revealed that extranodal extension (ENE) of lymph-node metastases independently influences survival. Therefore, the aim of the present study was to evaluate novel molecular subtyping with regard to the growth pattern of lymph-node metastases.A total of 189 gastric carcinomas with lymph-node metastases were analyzed. The expression of p53, SOX2, SOX9, and the mismatch-repair gene products MLH1, PMS2, MSH2, and MSH6 were analyzed by immunohistochemistry. To determine the correlation with EBV infection, in situ hybridization for EBV-encoded small RNA (EBER) was applied.ENE was present in 36% of patients. EBV-positive carcinoma was evident in 5.8%, and p53 aberrant (chromosomal instable) tumors in 22.2%, a gastric cancer with deficient mismatch-repair status in 9%, and MSS/p53neg/EBVneg tumors were seen in 63% of patients. There was no significant correlation between the presence or absence of ENE and the molecular subtypes. However, a significant association between molecular subgroups and the Lauren classification, the oncogene SOX2, and tumor grading was detected.The present findings suggest that alterations in gastric cancer leading to ENE are not associated with alterations underpinning the molecular subgroups. Nonetheless, molecular subtyping on the basis of IHC and ISH is feasible and might become clinical routine. Thus, further studies are needed to clarify the mechanisms of extranodal extension in gastric cancer.
000144854 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000144854 542__ $$2Crossref$$i2019-09-20$$uhttp://www.springer.com/tdm
000144854 542__ $$2Crossref$$i2019-09-20$$uhttp://www.springer.com/tdm
000144854 588__ $$aDataset connected to CrossRef, PubMed,
000144854 7001_ $$aTodorova, Rumyana$$b1
000144854 7001_ $$aLink, Helena$$b2
000144854 7001_ $$aWestphalen, C Benedikt$$b3
000144854 7001_ $$aBoeck, Stefan$$b4
000144854 7001_ $$aHeinemann, Volker$$b5
000144854 7001_ $$aWerner, Jens$$b6
000144854 7001_ $$0P:(DE-He78)fd68f49dada874ac262fadf9fde869df$$aKirchner, Thomas$$b7$$udkfz
000144854 7001_ $$aAngele, Martin K$$b8
000144854 7001_ $$0P:(DE-HGF)0$$aNeumann, Jens$$b9$$eLast author
000144854 77318 $$2Crossref$$3journal-article$$a10.1007/s00432-019-03029-4$$bSpringer Science and Business Media LLC$$d2019-09-20$$n11$$p2689-2697$$tJournal of Cancer Research and Clinical Oncology$$v145$$x0171-5216$$y2019
000144854 773__ $$0PERI:(DE-600)1459285-X$$a10.1007/s00432-019-03029-4$$n11$$p2689-2697$$tJournal of cancer research and clinical oncology$$v145$$x0171-5216$$y2019
000144854 909CO $$ooai:inrepo02.dkfz.de:144854$$pVDB
000144854 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fd68f49dada874ac262fadf9fde869df$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000144854 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000144854 9141_ $$y2019
000144854 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144854 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144854 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144854 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CANCER RES CLIN : 2015
000144854 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000144854 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000144854 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000144854 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000144854 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144854 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144854 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000144854 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000144854 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000144854 9201_ $$0I:(DE-He78)E131-20160331$$kE131$$lComputer-assistierte Interventionen$$x0
000144854 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x1
000144854 980__ $$ajournal
000144854 980__ $$aVDB
000144854 980__ $$aI:(DE-He78)E131-20160331
000144854 980__ $$aI:(DE-He78)L101-20160331
000144854 980__ $$aUNRESTRICTED
000144854 999C5 $$1S Ahn$$2Crossref$$9-- missing cx lookup --$$a10.1097/PAS.0000000000000756$$p106 -$$tAm J Surg Pathol$$uAhn S, Lee SJ, Kim Y, Kim A, Shin N et al (2017) High-throughput protein and mRNA expression-based classification of gastric cancers can identify clinically distinct subtypes, concordant with recent molecular classifications. Am J Surg Pathol 41:106–115. https://doi.org/10.1097/PAS.0000000000000756$$v41$$y2017
000144854 999C5 $$1H Alakus$$2Crossref$$9-- missing cx lookup --$$a10.1002/cncr.24764$$p309 -$$tCancer$$uAlakus H, Holscher AH, Grass G, Hartmann E, Schulte C et al (2010) Extranodal lymph node spread: a new prognostic factor in gastric cancer. Cancer 116:309–315. https://doi.org/10.1002/cncr.24764$$v116$$y2010
000144854 999C5 $$1EM Birkman$$2Crossref$$9-- missing cx lookup --$$a10.1007/s00428-017-2240-x$$p369 -$$tVirchows Arch$$uBirkman EM, Mansuri N, Kurki S, Algars A, Lintunen M et al (2018) Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. Virchows Arch 472:369–382. https://doi.org/10.1007/s00428-017-2240-x$$v472$$y2018
000144854 999C5 $$1F Bosch$$2Crossref$$9-- missing cx lookup --$$a10.1530/ERC-18-0494$$p293 -$$tEndocr Relat Cancer$$uBosch F, Bruwer K, Altendorf-Hofmann A, Auernhammer CJ, Spitzweg C et al (2019) Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia. Endocr Relat Cancer 26:293–301. https://doi.org/10.1530/ERC-18-0494$$v26$$y2019
000144854 999C5 $$1Cancer Genome Atlas Research N$$2Crossref$$9-- missing cx lookup --$$a10.1038/nature13480$$p202 -$$tNature$$uCancer Genome Atlas Research N (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209. https://doi.org/10.1038/nature13480$$v513$$y2014
000144854 999C5 $$1R Cristescu$$2Crossref$$9-- missing cx lookup --$$a10.1038/nm.3850$$p449 -$$tNat Med$$uCristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC et al (2015) Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 21:449–456. https://doi.org/10.1038/nm.3850$$v21$$y2015
000144854 999C5 $$1D Cunningham$$2Crossref$$9-- missing cx lookup --$$a10.1056/NEJMoa055531$$p11 -$$tN Engl J Med$$uCunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20. https://doi.org/10.1056/NEJMoa055531$$v355$$y2006
000144854 999C5 $$1B Fakhri$$2Crossref$$9-- missing cx lookup --$$a10.21037/jgo.2016.11.01$$p379 -$$tJ Gastrointest Oncol$$uFakhri B, Lim KH (2017) Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature. J Gastrointest Oncol 8:379–386. https://doi.org/10.21037/jgo.2016.11.01$$v8$$y2017
000144854 999C5 $$1J Ferlay$$2Crossref$$9-- missing cx lookup --$$a10.1002/ijc.29210$$pE359 -$$tInt J Cancer$$uFerlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210$$v136$$y2015
000144854 999C5 $$1RS Gonzalez$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.humpath.2016.06.003$$p16 -$$tHum Pathol$$uGonzalez RS, Messing S, Tu X, McMahon LA, Whitney-Miller CL (2016) Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma. Hum Pathol 56:16–21. https://doi.org/10.1016/j.humpath.2016.06.003$$v56$$y2016
000144854 999C5 $$1B Hu$$2Crossref$$9-- missing cx lookup --$$a10.3978/j.issn.2078-6891.2012.021$$p251 -$$tJ Gastrointest Oncol$$uHu B, El Hajj N, Sittler S, Lammert N, Barnes R et al (2012) Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol 3:251–261. https://doi.org/10.3978/j.issn.2078-6891.2012.021$$v3$$y2012
000144854 999C5 $$1K Hutz$$2Crossref$$9-- missing cx lookup --$$a10.1093/carcin/bgt410$$p942 -$$tCarcinogenesis$$uHutz K, Mejias-Luque R, Farsakova K, Ogris M, Krebs S et al (2014) The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells. Carcinogenesis 35:942–950. https://doi.org/10.1093/carcin/bgt410$$v35$$y2014
000144854 999C5 $$1A Jemal$$2Crossref$$9-- missing cx lookup --$$a10.3322/caac.20107$$p69 -$$tCA Cancer J Clin$$uJemal A, Bray F, Center MM, Ferlay J, Ward E et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. https://doi.org/10.3322/caac.20107$$v61$$y2011
000144854 999C5 $$1HS Kim$$2Crossref$$9-- missing cx lookup --$$a10.18632/oncotarget.10115$$p44608 -$$tOncotarget$$uKim HS, Shin SJ, Beom SH, Jung M, Choi YY et al (2016) Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy. Oncotarget 7:44608–44620. https://doi.org/10.18632/oncotarget.10115$$v7$$y2016
000144854 999C5 $$1P Lauren$$2Crossref$$9-- missing cx lookup --$$a10.1111/apm.1965.64.1.31$$p31 -$$tActa Pathol Microbiol Scand$$uLauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49$$v64$$y1965
000144854 999C5 $$1IS Lee$$2Crossref$$9-- missing cx lookup --$$a10.1002/bjs.9640$$p1576 -$$tBr J Surg$$uLee IS, Park YS, Ryu MH, Song MJ, Yook JH et al (2014) Impact of extranodal extension on prognosis in lymph node-positive gastric cancer. Br J Surg 101:1576–1584. https://doi.org/10.1002/bjs.9640$$v101$$y2014
000144854 999C5 $$1H Link$$2Crossref$$9-- missing cx lookup --$$a10.1186/s12885-018-4413-7$$p483 -$$tBMC Cancer$$uLink H, Angele M, Schuller M, Ganschow P, Machetanz L et al (2018) Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer. BMC Cancer 18:483. https://doi.org/10.1186/s12885-018-4413-7$$v18$$y2018
000144854 999C5 $$1C Luchini$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.suronc.2015.09.005$$p60 -$$tSurg Oncol$$uLuchini C, Nottegar A, Solmi M, Sergi G, Manzato E et al (2016) Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: a systematic review and meta-analysis. Surg Oncol 25:60–65. https://doi.org/10.1016/j.suronc.2015.09.005$$v25$$y2016
000144854 999C5 $$1J Matsuoka$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jss.2010.11.903$$p130 -$$tJ Surg Res$$uMatsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H et al (2012) Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res 174:130–135. https://doi.org/10.1016/j.jss.2010.11.903$$v174$$y2012
000144854 999C5 $$1SH Noh$$2Crossref$$9-- missing cx lookup --$$a10.1016/S1470-2045(14)70473-5$$p1389 -$$tLancet Oncol$$uNoh SH, Park SR, Yang HK, Chung HC, Chung IJ et al (2014) Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 15:1389–1396. https://doi.org/10.1016/S1470-2045(14)70473-5$$v15$$y2014
000144854 999C5 $$1H Rokutan$$2Crossref$$9-- missing cx lookup --$$a10.1002/path.5208$$tJ Pathol$$uRokutan H, Abe H, Nakamura H, Ushiku T, Arakawa E et al (2018) Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia. J Pathol. https://doi.org/10.1002/path.5208$$y2018
000144854 999C5 $$1N Setia$$2Crossref$$9-- missing cx lookup --$$a10.1038/modpathol.2016.55$$p772 -$$tMod Pathol$$uSetia N, Agoston AT, Han HS, Mullen JT, Duda DG et al (2016) A protein and mRNA expression-based classification of gastric cancer. Mod Pathol 29:772–784. https://doi.org/10.1038/modpathol.2016.55$$v29$$y2016
000144854 999C5 $$1T Tian$$2Crossref$$9-- missing cx lookup --$$a10.7555/JBR.26.20120045$$p336 -$$tJ Biomed Res$$uTian T, Zhang Y, Wang S, Zhou J, Xu S (2012) Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J Biomed Res 26:336–345. https://doi.org/10.7555/JBR.26.20120045$$v26$$y2012
000144854 999C5 $$1N Veronese$$2Crossref$$9-- missing cx lookup --$$a10.1093/annonc/mdv494$$p42 -$$tAnn Oncol$$uVeronese N, Nottegar A, Pea A, Solmi M, Stubbs B et al (2016) Prognostic impact and implications of extranodal lymph node involvement in colorectal cancer: a systematic review with meta-analysis. Ann Oncol 27:42–48. https://doi.org/10.1093/annonc/mdv494$$v27$$y2016